NCT05036694View on ClinicalTrials.gov

Diagnostic Performance of a Novel Lipoarabinomannan.

NAUnknownINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2022

Conditions
HIV Primary Infection
Interventions
DEVICE

FUJILAM KIT

Urine based test to detect LAM

Sponsors

Collaborators (1)

Epicentre
All Listed Sponsors
collaborator

Epicentre

OTHER

lead

Médecins Sans Frontières, Kenya

OTHER

NCT05036694 - Diagnostic Performance of a Novel Lipoarabinomannan. | Biotech Hunter | Biotech Hunter